Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
FAIR 0.060 +33.3% SVRS 0.430 +0.0% RES 0.035 +0.0% CYG 0.120 +0.0% MGG 0.325 −1.5% BUFF 0.800 +6.7% TKO 10.80 +8.4% MINK 0.115 +9.5% LCE 0.250 +0.0% AEF 0.160 +0.0% BEM 0.095 +5.6% APMI 0.120 +0.0% LIO 0.135 +3.9% KC 0.260 −3.7% NOVA 0.170 +3.0% FAIR 0.060 +33.3% SVRS 0.430 +0.0% RES 0.035 +0.0% CYG 0.120 +0.0% MGG 0.325 −1.5% BUFF 0.800 +6.7% TKO 10.80 +8.4% MINK 0.115 +9.5% LCE 0.250 +0.0% AEF 0.160 +0.0% BEM 0.095 +5.6% APMI 0.120 +0.0% LIO 0.135 +3.9% KC 0.260 −3.7% NOVA 0.170 +3.0%

Healthcare

Page 55
  1. Feb 27, 2026 · 20:41 · DTC

    Defence Therapeutics arranges $11-million financing

    Defence Therapeutics arranges $11-million financing

    01
  2. Feb 27, 2026 · 20:18 · NVRS

    Noveris convertible debenture acquired by JJK Holdings

    Noveris convertible debenture acquired by JJK Holdings

    02
  3. Feb 27, 2026 · 19:11 · TELO

    Telo Genomics increases private placement to $1.6M

    Telo Genomics increases private placement to $1.6M

    03
  4. Feb 27, 2026 · 17:22 · SHRX

    Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

    Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

    04
  5. Feb 27, 2026 · 17:01 · DTC

    Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million

    Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million

    05
  6. Feb 27, 2026 · 16:35 · NVRS

    JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited

    JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited

    06
  7. Feb 27, 2026 · 16:30 · INNO

    FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

    FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

    07
  8. Feb 27, 2026 · 15:33 · TELO

    Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement

    Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement

    08
  9. Feb 27, 2026 · 11:44 · MDX

    MedX Health closes $2.7-million private placement

    MedX Health closes $2.7-million private placement

    09
  10. Feb 27, 2026 · 07:00 · MDX

    MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes

    MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes

    10
  11. Feb 27, 2026 · 04:52 · BNXT

    Bionxt issues six million shares for debt of $2.7M

    Bionxt issues six million shares for debt of $2.7M

    11
  12. Feb 26, 2026 · 19:00 · BNXT

    BioNxt Announces Closing of Shares for Debt Settlement

    BioNxt Announces Closing of Shares for Debt Settlement

    12
  13. Feb 26, 2026 · 17:17 · EDT

    Spectral delays seeking premarket OK for PMX to mid-May

    Spectral delays seeking premarket OK for PMX to mid-May

    13
  14. Feb 26, 2026 · 17:01 · DTR

    DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye

    DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye

    14
← Newer Older →